Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.

about

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia.

P2860

Q33770150-F47E91C7-97BF-41BD-8D4B-57502251AECA

P2860

Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.

Item

http://www.wikidata.org/entity/Q40598104

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment of children with acu ...... Korean study of 295 patients.

@en

type

Item

label

Treatment of children with acu ...... Korean study of 295 patients.

@en

prefLabel

Treatment of children with acu ...... Korean study of 295 patients.

@en

P1476

Treatment of children with acu ...... Korean study of 295 patients.

@en

P2093

Bin Cho

http://www.w3.org/2001/XMLSchema#string

Dae-Chul Jeong

http://www.w3.org/2001/XMLSchema#string

Hack-Ki Kim

http://www.w3.org/2001/XMLSchema#string

Jae Wook Lee

http://www.w3.org/2001/XMLSchema#string

Nack-Gyun Chung

http://www.w3.org/2001/XMLSchema#string

Pil-Sang Jang

http://www.w3.org/2001/XMLSchema#string

Seong-Koo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

P304

1966-1973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.26136

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27463364

http://www.w3.org/2001/XMLSchema#string

Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.

about

P2860

P2860

Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698